Most life sciences companies depend on enterprise systems that go by three letter acronyms we know well (ERP, MES, PLM, SCM, QMS, etc.) to deliver critical customer service, operational, regulatory and compliance capabilities. When the implementation and regulatory compliance of these systems are led by system integrators using a large number of offshore resources, the promises are attractive: lower labor rates, scale, supposed global best practices. But buyer beware!
Key Takeaways
- High-profile lawsuits in life sciences show how offshore-dependent IT projects can balloon over budget, stall operations, and trigger litigation.
- Physical, time-zone, cultural, and stakeholder distance erode communication and knowledge transfer—risks that are amplified in highly regulated GxP environments.
- Local, life-sciences-fluent expertise delivers immediate responsiveness, clear accountability, and built-in regulatory rigor.
- For systems that touch patient safety and compliance, the perceived savings of offshore models can evaporate in rework and remediation.
Recent high-profile lawsuits in the life sciences industry serve as stark reminders of the financial and operational risks companies face when embarking on large IT projects with system integrators relying heavily on offshore resources. The recent $172 million lawsuit filed by medical device giant Zimmer Biomet against a major consulting firm highlights what happens when offshore-dependent approaches go wrong—with claims that the consulting team was "incompetent and unqualified" and delivered a "wholly defective" system that crippled operations.
The Real Cost of Going Offshore
The Zimmer Biomet case illustrates how offshore projects can spiral out of control: what began as a $69 million contract ballooned to $94 million—36% over the represented cost—before ultimately requiring an additional $72 million in post-go-live remediation efforts. Beyond immediate financial losses, the company faced:
- Operational paralysis: The company was "barely operational through the third quarter of 2024, unable to ship or receive product, issue invoices, or generate basic sales reporting".
- Patient safety risks: Disruptions to the global supply chain prevented timely shipment of critical medical devices to doctors and patients, putting patient care at risk.
- Market confidence erosion: The mounting challenges forced Zimmer Biomet to reduce its full-year 2024 guidance, contributing to significant market cap erosion.
This case isn't isolated. The life sciences industry has witnessed multiple ERP implementation failures that share similar offshore-related challenges:
- Revlon's SAP Implementation Disaster: The cosmetics company's ERP failure resulted in $64 million in lost sales, manufacturing disruptions, and shareholder lawsuits after implementation issues at their North Carolina facility prevented fulfillment to major retail customers. The project was managed by a major consulting firm that allegedly underbid the project and lacked adequate expertise with the new SAP S/4HANA system.
- Avantor Performance Materials Sues their SAP SI: The biotechnology, chemicals and pharmaceutical products manufacturer sued their SI, alleging the consulting giant lied about their "Express Life Sciences Solution" being suitable for Avantor's business, bringing operations to "a near standstill" and causing tens of millions in damages. The case demonstrates how large system integrators have been known to oversell their capabilities in specialized life sciences environments.
When projects fail to deliver on time, on budget, and with the required functionality, the perceived cost savings of offshore development can quickly evaporate—replaced by rework, remediation, and litigation.
Why Offshore IT Projects Fail in Life Sciences
Research reveals that offshore projects tend to be unsuccessful because physical, time, cultural, organizational, and stakeholder distances negatively influence communication and knowledge exchange. In highly regulated life sciences environments, these challenges are amplified:
Four Distances That Derail Offshore Delivery
- Time Zone Coordination: Round-the-clock development often results in losing two days instead of gaining one, as issues require extensive documentation and real-time back-and-forth communication in order to avoid miscommunication—resulting in your onshore people finding out in their morning that the offshore team did not understand the full context of the objective they were expected to address.
- Communication Barriers: Language nuances and cultural differences create miscommunication risks, requiring extensive documentation and verification processes that can actually slow progress rather than accelerate it. This is especially critical when dealing with the intricate FDA, EMA and other regulatory frameworks with which life sciences companies must comply.
- Knowledge Transfer Gaps: Large system integrators often rely on high percentages of junior programmers offshore who lack requisite business knowledge, technical skills, and cultural understanding critical for complex life sciences applications.
- Project Management Challenges: Research shows that miscommunication of problem specificity and inadequate documentation frequently cause offshore teams to work on wrong issues, requiring costly rework.
In regulated life sciences, the cost of miscommunication isn't just rework—it can become a compliance gap. Distance between teams makes it harder to maintain the validation evidence and audit trails that Computer Software Assurance (CSA) and 21 CFR Part 11 demand, and harder to enforce the controls expected under sound governance and compliance practices.
The USDM Life Sciences Advantage
Unlike large, tier 1 system integrators that rely heavily on offshore resources, USDM Life Sciences takes a fundamentally different approach by leveraging local experts who understand both the technical and regulatory nuances of life sciences operations.
Deep Industry Knowledge: Our consultants possess extensive experience in GxP environments, FDA validation requirements, and life sciences business processes—expertise that can't be easily outsourced or transferred.
Direct Client Relationships: With local resources, communication is immediate and nuanced. There are no language barriers, cultural misunderstandings, or time zone delays that can derail critical project phases.
Regulatory Expertise: Life sciences companies must maintain privacy, confidentiality, and security as absolutes, requiring integration platforms that comply with industry best-practice approaches. Our local teams understand these requirements intimately and can ensure Computer System Validation (CSV) and Computer Software Assurance (CSA) compliance, supported by disciplined validation lifecycle management that keeps systems audit-ready as they evolve.
Agile Responsiveness: When issues arise—and they always do in complex IT implementations—local teams can respond immediately rather than waiting for offshore resources to come online or requiring extensive documentation to explain problems across geographic boundaries.
Accountability: Unlike offshore models where responsibility is often diffused across multiple teams and time zones, our local approach ensures direct accountability and clear ownership of project outcomes. Where third parties remain part of the delivery model, that accountability extends to disciplined third-party risk management and cybersecurity controls.
Making the Right Choice
The mounting evidence from cases like Zimmer Biomet, Revlon, and Avantor demonstrate that the perceived cost savings of offshore development can quickly evaporate when projects fail to deliver on time, on budget, and with the required functionality. As one analyst noted about these failures, large system integrators often "bite off more than they can chew" and "misrepresent the capability of their ERP system" to win business.
For life sciences companies, the stakes are too high to risk on offshore-dependent system integrators. Patient safety, regulatory compliance, and operational continuity demand partners who understand the unique challenges of the industry and can provide immediate, knowledgeable support throughout the project lifecycle.
USDM Life Sciences offers that local expertise, regulatory knowledge, and direct accountability that ensures your IT projects deliver real value rather than costly litigation. When your next critical system implementation is on the line, choose the partner who's in your time zone, speaks your language, and understands your business.
FAQ: Offshore IT Projects and Local Expertise in Life Sciences
Why do offshore IT projects fail more often in life sciences?
Life sciences systems operate under strict FDA, EMA, and other regulatory frameworks. The physical, time-zone, cultural, organizational, and stakeholder distances inherent to offshore delivery degrade communication and knowledge transfer—and those gaps are especially damaging when validation evidence, documentation, and regulatory context must be precise.
What are the hidden costs of offshore-dependent system integrators?
Beyond headline labor savings, organizations have faced budget overruns, post-go-live remediation, operational paralysis, supply chain disruption, and litigation. As seen in cases like Zimmer Biomet, Revlon, and Avantor, the true cost surfaces when projects fail to deliver on time, on budget, and with required functionality.
How does local expertise reduce regulatory risk?
Local, GxP-fluent teams understand FDA validation requirements and life sciences business processes intimately. They can ensure Computer System Validation (CSV) and Computer Software Assurance (CSA) compliance, maintain the audit trails expected under 21 CFR Part 11, and respond immediately when issues arise rather than waiting across time zones.
Does choosing local expertise mean giving up scale or innovation?
No. The goal is direct accountability and life-sciences fluency, not slower delivery. Local teams can move faster on critical project phases because communication is immediate and nuanced—eliminating the documentation overhead and rework cycles that stall offshore-heavy programs.
Planning a critical ERP, MES, QMS, or PLM implementation? Choose a partner who is in your time zone, speaks your language, and understands your regulatory reality. Contact USDM Life Sciences to discuss how local expertise and direct accountability can de-risk your next enterprise system project.